Back to modules
Module 04  ·  Coming Soon

HTA·Axi — Health Technology
Assessment Intelligence

Navigate HTA bodies, dossier standards, and value evidence requirements across 40+ countries. Reduce submission risk, anticipate evaluator questions, and accelerate time to positive reimbursement decisions.

40+
HTA bodies covered
67%
Of submissions lack optimal evidence packages
18mo
Average time lost to avoidable HTA failures
$300M+
Revenue at risk per delayed market
The Reality

The dossier process is broken — and it costs years

HEOR teams spend more time formatting Word documents than generating evidence. HTA·Axi changes that.

67%
Of HTA submissions arrive with evidence gaps evaluators have already signalled — gaps that were entirely avoidable.
18 mo
Average time lost when a submission is returned for supplementary evidence — that is peak-sales revenue gone.
Word doc
Still the dominant dossier format in most markets — with methodology buried in footnotes, invisible to HEOR teams reviewing it.
3×
Higher resubmission rate for dossiers that failed to scan prior HTA precedents in the same target country.
Capabilities

Precision evidence, faster decisions

HTA·Axi maps the evidence landscape for every major HTA body — so your HEOR and market access teams build submissions that land, not ones that get sent back for revision.

Dossier Intelligence
HTA Body Requirements Mapping

Comprehensive mapping of dossier standards, evidence thresholds, and submission formats for 40+ HTA bodies. Understand exactly what each evaluator requires before you start building your package.

Evidence Gaps
Value Evidence Gap Analysis

Identify where your clinical, economic, and real-world evidence package falls short of evaluator expectations — before submission. Prioritise evidence generation investments for maximum HTA impact.

Submission Strategy
Sequencing & Timing Optimisation

Determine the optimal HTA submission sequence across markets. Identify which body's positive decision carries the most weight with downstream evaluators and plan accordingly.

Outcome Prediction
HTA Decision Forecasting

Predict the probability of positive HTA outcomes based on your evidence profile, comparator landscape, and body-specific historical patterns. Quantify risk before you commit resources.

The Strategic Imperative

Why HTA·Axi exists

67%
Of HTA submissions arrive with evidence gaps that could have been anticipated and resolved pre-submission
18mo
Average time lost when a submission is returned for supplementary evidence — revenue that is simply gone
$300M+
Revenue at risk per delayed market for a mid-tier launch — costs that dwarf any investment in HTA intelligence
Get Started

Request access to HTA·Axi

Equip your HEOR and market access teams with the HTA intelligence needed to build submissions that win the first time.

Request Early Access